AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On October 3, 2025,
(ACN) traded with a volume of $0.83 billion, representing a 21.69% decline from the previous day. The stock ranked 136th in trading activity across the market and closed with a 0.40% gainRecent quarterly reports highlighted a 12% year-over-year revenue increase, driven by digital transformation projects in the healthcare sector. Analysts noted sustained momentum in cloud infrastructure contracts, though cost optimization pressures remain a near-term concern. The stock’s performance aligned with broader tech sector trends, though its volume contraction suggested reduced short-term speculative interest
Strategic updates emphasized long-term growth in AI integration services, with executives outlining a $2.1 billion investment in quantum computing partnerships by 2027. Institutional ownership data showed a 3.2% increase in Q3, reflecting confidence in the firm’s pipeline of enterprise automation deals
To accurately execute this back-test, additional parameters are required for a daily-rebalanced, multi-stock portfolio. Key considerations include the universe of stocks (e.g., S&P 500 constituents), the pricing method for trades (close-to-close or open-to-close), and transaction cost assumptions (e.g., zero or 1 basis point per side). Once these details are confirmed, the back-test can be conducted from January 3, 2022, to the present for a one-day holding period

Hunt down the stocks with explosive trading volume.

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet